AbbVie Healthcare India rejects wrongdoing allegations by the Department of Pharmaceuticals

AbbVie Healthcare India has denied accusations of unethical marketing by the Department of Pharmaceuticals, asserting their compliance with applicable laws. The DoP flagged AbbVie for breaching the Uniform Code for Pharmaceutical Marketing Practices by sponsoring luxurious trips for doctors, leading to a probe into the company's tax liabilities and potential professional repercussions for the involved healthcare practitioners.